Association between VDR Apa I polymorphism and subclinical hypothyroidism in patients with polycystic ovary syndrome: a pilot study

Gynecological Endocrinology · Published 2025-10-06 · DOI 10.1080/09513590.2025.2566341

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1080/09513590.2025.2566341

Abstract

Purpose To investigate the association between vitamin D receptor (VDR) gene polymorphisms and sub-clinical hypothyroidism (SCH) risk in polycystic ovary syndrome (PCOS) patients.Methods Forty-four PCOS patients and 24 controls were enrolled. VDR gene sequences, lipid profiles, and thyroid function were analyzed, with stratification by SCH status for group comparisons.Results PCOS patients showed significant differences in fasting glucose, triglycerides, and BMI vs. controls. SCH patients exhibited distinct Apa I genotypes (P < 0.05), with the AC genotype rate (76.47%) significantly higher in PCOS + SCH vs. other groups. Unadjusted/adjusted ORs for SCH patients with the AC genotype were 4.2 (95% CI 1.40–13.10), 5.01 (95% CI 1.53–16.38), and 6.25 (95% CI 1.69–23.09). No other polymorphisms were significant.Conclusion This study revealed that the VDR Apa I genotype (AC as a distinct risk factor) was associated with SCH in PCOS patients, suggesting new genetic insights.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2025

Related articles